Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Gastrointest Endosc. Jan 16, 2024; 16(1): 18-28
Published online Jan 16, 2024. doi: 10.4253/wjge.v16.i1.18
Table 1 Demographics of the study patients, n (%)
Characteristics
Group 11, n = 148
Group 22, n = 156
P value
Age in yr65.76 ± 7.84366.99 ± 9.3370.377
Male sex 100 (67.6)105 (67.3)0.961
Lifestyle habits
  Current smoking30 (20.3)33 (21.2)0.849
  Smoking history63 (42.6)66 (42.3)0.963
  Current drinking34 (23.0)35 (22.4)0.911
  Drinking history40 (27.0)41 (26.3)0.883
History of abdominopelvic surgery41 (27.9)56 (36.1)0.125
Comorbidity
  Constipation19 (12.8)25 (16.0)0.430
  Drugs for constipation7 (4.7)10 (6.4)0.524
  Diabetes64 (43.2)74 (47.4)0.463
  Hypertension86 (58.1)89 (57.4)0.903
  Chronic heart failure2 (1.4)4 (2.6)0.728
  Coronary heart disease19 (12.8)34 (21.8)0.040
  Chronic kidney disease (≥ stage 2)99 (66.8)89 (57.0)0.280
  Chronic obstructive pulmonary disease6 (4.1)8 (5.1)0.655
Nutritional status
  BMI in kg/m224.325 ± 3.04924.569 ± 2.9360.718
  Hemoglobin in g/L135.91 ± 15.903135.30 ± 15.9060.675
  Albumin in g/L39.542 ± 3.089539.469 ± 3.78270.710
Interval between last dose of laxatives and colonoscopy in h4.71 ± 1.2484.26 ± 1.3150.003